International Journal of Hematology and Oncology
2025 , Vol 35 , Num 3
Ozlem ERCELEP, Selver ISIK, Ece ERCAN, Osman KOSTEK, Vedat BAYOGLU, Abdussamet CELEBI, Nadiye SEVER, Nergiz MECIDOVA, Erkam KOCAASLAN, Pinar EREL, Yesim AGYOL, Ali Kaan GUVEN, Feyza SEN, Derya KOCAKAYA, Emine BOZKURTLAR, Rukiye ARIKAN, Murat SARI
The Effect of PET/CT SUV max Value on Anti-EGFR Treatment Response in Lung Adenocarcinoma. UHOD , 2025 , 35 , 159-165
Serra KAMER, Cagri HIDIMOGLU, Sinan HOCA, Serap AKSOYLAR, Gulcihan OZEK, Yavuz ANACAK Total Body Irradiation as a Component of Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric ALL. UHOD , 2025 , 35 , 166-171
Ipek Pinar ARAL, Gonca ALTINISIK INAN, Fatma Betul AYRAK, Tarik KARGIOGLU, Mehmet SONMEZ, Nalan ASLAN, Huseyin Furkan OZTURK, Yilmaz TEZCAN Surgery and Hypofractionated Radiotherapy Improve Local Control in High-Risk Head and Neck Non-Melanoma Skin Cancer. UHOD , 2025 , 35 , 172-177
Gokhan SAHIN, Oguzcan OZKAN, Caner ACAR, Haydar Cagatay YUKSEL, Sercan ON, Hasan Cagri YILDIRIM, Burcu CAKAR, Erhan GOKMEN Real-World Pathologic Complete Response Rates with Neoadjuvant Pembrolizumab in Stage II–III Triple-Negative Breast Cancer: Impact of Ki-67 Proliferation Index. UHOD , 2025 , 35 , 178-185
Goksen INANC IMAMOGLU, Enes YESILBAS, Galip Can UYAR Real-World Predictors of Pathologic Response to FLOT in Patients with Resectable Gastric Cancer: A Retrospective Analysis. UHOD , 2025 , 35 , 186-192
Metin Yusuf GELMEZ, Suzan CINAR, Aynur DAGLAR-ADAY, Gulce OZCIT, Murat OZBALAK, Tugba USTA, Ipek YONAL-HINDILERDEN, Gunnur DENIZ Can BATF Expression Serve as a Predictive Marker for Treatment Necessity in Chronic Lymphocytic Leukemia?. UHOD , 2025 , 35 , 193-201
Volkan KARAKUS, Ibrahim Ethem PINAR, Ayse KARADURU Limited Role of Plasma Exchange in Multiple Myeloma-Associated Acute Kidney Injury: Chemotherapy as the Cornerstone of Renal Recovery. UHOD , 2025 , 35 , 202-211
Ebru KILIC GUNES, Emine Merve SAVAS, Batuhan ERDOGDU, Ufuk GORDUK, Duygu GUL, Hacer Berna AFACAN OZTURK, Ahmet Kursad GUNES, Meltem AYLI Clinical Outcomes and Prognostic Factors in AML with Hyperleukocytosis: A Multicenter Real-World Study. UHOD , 2025 , 35 , 212-220
Serra KAMER, Cagri HIDIMOGLU, Sinan HOCA, Serap AKSOYLAR, Gulcihan OZEK, Yavuz ANACAK Total Body Irradiation as a Component of Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric ALL. UHOD , 2025 , 35 , 166-171
Ipek Pinar ARAL, Gonca ALTINISIK INAN, Fatma Betul AYRAK, Tarik KARGIOGLU, Mehmet SONMEZ, Nalan ASLAN, Huseyin Furkan OZTURK, Yilmaz TEZCAN Surgery and Hypofractionated Radiotherapy Improve Local Control in High-Risk Head and Neck Non-Melanoma Skin Cancer. UHOD , 2025 , 35 , 172-177
Gokhan SAHIN, Oguzcan OZKAN, Caner ACAR, Haydar Cagatay YUKSEL, Sercan ON, Hasan Cagri YILDIRIM, Burcu CAKAR, Erhan GOKMEN Real-World Pathologic Complete Response Rates with Neoadjuvant Pembrolizumab in Stage II–III Triple-Negative Breast Cancer: Impact of Ki-67 Proliferation Index. UHOD , 2025 , 35 , 178-185
Goksen INANC IMAMOGLU, Enes YESILBAS, Galip Can UYAR Real-World Predictors of Pathologic Response to FLOT in Patients with Resectable Gastric Cancer: A Retrospective Analysis. UHOD , 2025 , 35 , 186-192
Metin Yusuf GELMEZ, Suzan CINAR, Aynur DAGLAR-ADAY, Gulce OZCIT, Murat OZBALAK, Tugba USTA, Ipek YONAL-HINDILERDEN, Gunnur DENIZ Can BATF Expression Serve as a Predictive Marker for Treatment Necessity in Chronic Lymphocytic Leukemia?. UHOD , 2025 , 35 , 193-201
Volkan KARAKUS, Ibrahim Ethem PINAR, Ayse KARADURU Limited Role of Plasma Exchange in Multiple Myeloma-Associated Acute Kidney Injury: Chemotherapy as the Cornerstone of Renal Recovery. UHOD , 2025 , 35 , 202-211
Ebru KILIC GUNES, Emine Merve SAVAS, Batuhan ERDOGDU, Ufuk GORDUK, Duygu GUL, Hacer Berna AFACAN OZTURK, Ahmet Kursad GUNES, Meltem AYLI Clinical Outcomes and Prognostic Factors in AML with Hyperleukocytosis: A Multicenter Real-World Study. UHOD , 2025 , 35 , 212-220